Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin and the ischaemic heart.

Cherry L Wainwright1, Christopher McCabe, Kathleen A Kane

  • 1School of Pharmacy, The Robert Gordon University, Aberdeen, UK. c.wainwright@rgu.ac.uk

Current Vascular Pharmacology
|October 27, 2005
PubMed
Summary

Endothelin-1 (ET-1) has a complex role in heart attacks. While initially seen as harmful, ET-1 may also aid tissue repair and offer cardioprotection, requiring further research for therapeutic targeting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated BJP guidelines for transparent and rigorous natural product research.

British journal of pharmacology·2026
Same author

The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.

PloS one·2025
Same author

Defining early health technology assessment: building consensus using Delphi technique.

International journal of technology assessment in health care·2025
Same author

Putting the substance in substantial evidence: an evidence-based approach to flexible drug regulation.

Frontiers in medicine·2025
Same author

Cognitive Level Enhancement through Vision Exams and Refraction (CLEVER): study protocol for a randomised controlled trial.

Trials·2025
Same author

Short-Term Oral Administration of the Porcupine Inhibitor, Wnt-c59, Improves the Structural and Functional Features of Experimental HFpEF.

Pharmacology research & perspectives·2025

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Ischemic Heart Disease

Background:

  • Endothelin-1 (ET-1) is a potent vasoconstrictor peptide initially linked to myocardial ischemia-reperfusion injury.
  • Early studies suggested ET-1 contributes to injury and arrhythmias via ET(A) receptors.
  • Emerging evidence reveals a more complex role for ET-1 in the ischemic heart.

Purpose of the Study:

  • To explore the multifaceted roles of endothelin-1 (ET-1) in the context of myocardial ischemia and reperfusion.
  • To investigate the complex physiological actions of ET-1, including detrimental and potentially protective effects.
  • To clarify the mechanisms underlying ET-1's role in arrhythmogenesis and cardioprotection.

Main Methods:

  • Review of experimental studies on ET-1 receptor antagonists in ischemia-reperfusion models.
  • Analysis of recent evidence on ET-1's effects on cardiomyocyte apoptosis and mast cell degranulation.
  • Examination of conflicting studies on ET-1's direct electrophysiological effects versus ischemic mechanisms in arrhythmogenesis.

Main Results:

  • ET-1 exhibits both detrimental effects (vasoconstriction, NO inhibition) and potentially beneficial actions (inhibition of cardiomyocyte apoptosis).
  • ET-1-induced mast cell degranulation may represent a homeostatic mechanism for endogenous ET-1 regulation.
  • The precise mechanisms of ET-1-induced arrhythmogenesis and cardioprotection remain incompletely understood and debated.

Conclusions:

  • The role of ET-1 in the ischemic heart is complex, involving detrimental, reparative, and protective actions.
  • Further research is necessary to elucidate the complete physiology of ET-1 in normal and ischemic hearts.
  • Understanding these complex mechanisms is crucial for developing targeted therapeutic strategies.

Related Experiment Videos